Evidence map›Paper›PMID 28607832›Full record

ArticleHawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health2017

Headaches More Common among Epilepsy Sufferers with Neurocysticercosis than Other Structural Brain Lesions.

Erin K Saito, Bijal Mehta, Frances Wang, Beau Nakamoto, Aaron M McMurtray

Abstract read
In one paragraph

Article in Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Epilepsy in Asian countries.Acta epileptologica · 2023
    Review
  5. Current Diagnostic Criteria for Neurocysticercosis.Research and reports in tropical medicine · 2021
    Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Erin K SaitoNeurology Department, Los Angeles BioMedical Research Institute, Torrance, CA (EKS, BM, FW, AMM).
Bijal MehtaNeurology Department, Los Angeles BioMedical Research Institute, Torrance, CA (EKS, BM, FW, AMM).
Frances WangNeurology Department, Los Angeles BioMedical Research Institute, Torrance, CA (EKS, BM, FW, AMM).
Beau NakamotoNeurology Department, Los Angeles BioMedical Research Institute, Torrance, CA (EKS, BM, FW, AMM).
Aaron M McMurtrayNeurology Department, Los Angeles BioMedical Research Institute, Torrance, CA (EKS, BM, FW, AMM).

Funding

RESEARCH DESIGN AND BIOSTATISTICS COREU54MD007584 · NIMHD · UNIVERSITY OF HAWAII AT MANOA · PI MOKUAU, NOREEN, SHIRAMIZU, BRUCE T · 2012 to 2018
$21.1M
NIMHD NIH HHS U54 MD007584
6 · The paper itself

Abstract

Neurocysticercosis is a leading cause of seizures and epilepsy in the developing world. Cysticercosis is endemic in many regions of Central and South America, sub-Saharan Africa, India, and Asia. Neurocysticercosis is of emerging importance because globalization has increased travel between Hawai'i and disease-endemic areas. Headache and epilepsy are two of the most common complications of neurocysticercosis infection. Currently, it is not known if epilepsy patients with neurocysticercosis are more likely to have headaches than those with other structural brain lesions or those with no structural brain abnormalities. This study was designed to investigate whether epilepsy patients with neurocysticercosis report co-morbid headaches more frequently than those with other or with no structural brain lesions. A retrospective cross-sectional study of all patients treated at a community based neurology clinic for epilepsy during a three-month period was performed. One-hundred sixty patients were included in the analytical study. Co-morbid headaches were more commonly present among those with neurocysticercosis (40%) than those with other structural lesions and those with no structural brain abnormalities (19% and 22%, respectively;

Indexed as

PrevalenceAdultAnalysis of VarianceAnimalsCross-Sectional StudiesEpilepsyFemaleHeadacheHumansLos AngelesMaleMiddle AgedNeurocysticercosisRetrospective StudiesTaenia soliumepilepsyheadachesNeurocysticercosisseizure

Identifiers

PMID28607832
PMCPMC5458580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.